Garcia Carbonero, R., Bazan Peregrino, M., Gil Martin, M., Álvarez, R., Macarulla, T., Riesco Martinez, M. C., . . . Salazar Soler, R. (2022). Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors.
Citación estilo ChicagoGarcia Carbonero, Rocio, et al. Phase I, Multicenter, Open-label Study of Intravenous VCN-01 Oncolytic Adenovirus With or Without Nab-paclitaxel Plus Gemcitabine in Patients With Advanced Solid Tumors. 2022.
Cita MLAGarcia Carbonero, Rocio, et al. Phase I, Multicenter, Open-label Study of Intravenous VCN-01 Oncolytic Adenovirus With or Without Nab-paclitaxel Plus Gemcitabine in Patients With Advanced Solid Tumors. 2022.